相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment options in the modern management of Parkinson Disease
Anthony H. V. Schapira
ARCHIVES OF NEUROLOGY (2007)
Tau and α-synuclein in susceptibility to, and dementia in, Parkinson's disease
An Goris et al.
ANNALS OF NEUROLOGY (2007)
GDNF in Parkinson disease: An object lesson in the tyranny of type II
Michael Hutchinson et al.
JOURNAL OF NEUROSCIENCE METHODS (2007)
GDNF in Parkinson's disease: The perils of post-hoc power
James Matcham et al.
JOURNAL OF NEUROSCIENCE METHODS (2007)
Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo
Pivi Lindholm et al.
NATURE (2007)
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
C. H. Williams-Gray et al.
BRAIN (2007)
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
Michael G. Kaplitt et al.
LANCET (2007)
Pharmacologically active microcarriers releasing glial cell line -: derived neurotrophic factor:: Survival and differentiation of embryonic dopaminergic neurons after grafting in hemiparkinsonian rats
Valerie M. Tatard et al.
BIOMATERIALS (2007)
Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector
A. Chtarto et al.
EXPERIMENTAL NEUROLOGY (2007)
Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson's disease
Mehdi Gasmi et al.
MOLECULAR THERAPY (2007)
Role of brain-derived neurotrophic factor in Huntington's disease
Chiara Zuccato et al.
PROGRESS IN NEUROBIOLOGY (2007)
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
AE Lang et al.
ANNALS OF NEUROLOGY (2006)
Crossroads in GDNF therapy for Parkinson's disease
TB Sherer et al.
MOVEMENT DISORDERS (2006)
The expanding role of BDNF: a therapeutic target for Alzheimer's disease?
F Fumagalli et al.
PHARMACOGENOMICS JOURNAL (2006)
Neural repair strategies for Parkinson's disease: insights from primate models
Katherine Soderstrom et al.
CELL TRANSPLANTATION (2006)
Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease
M Sun et al.
BRAIN RESEARCH (2005)
The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease
T Foltynie et al.
JOURNAL OF NEUROLOGY (2005)
Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: A two-year outcome study
NK Patel et al.
ANNALS OF NEUROLOGY (2005)
Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time-and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system
B Georgievska et al.
JOURNAL OF NEUROSCIENCE (2004)
Placebo mechanisms and reward circuitry:: Clues from Parkinson's disease
R de la Fuente-Fernández et al.
BIOLOGICAL PSYCHIATRY (2004)
Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor:: Results of a phase I study
J Bloch et al.
HUMAN GENE THERAPY (2004)
Impact of placebo assignment in clinical trials of Parkinson's disease
CG Goetz et al.
MOVEMENT DISORDERS (2003)
Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease
V Arjona et al.
NEUROSURGERY (2003)
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
SS Gill et al.
NATURE MEDICINE (2003)
MANF - A new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons
PS Petrova et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2003)
Genetic fate of recombinant adeno-associated virus vector genomes in muscle
BC Schnepp et al.
JOURNAL OF VIROLOGY (2003)
Multiple actions of systemic artemin in experimental neuropathy
LR Gardell et al.
NATURE MEDICINE (2003)
In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson's disease
JH Kordower
ANNALS OF NEUROLOGY (2003)
Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease
D Kirik et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
CR Freed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Towards a neuroprotective gene therapy for Parkinson's disease:: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model
A Björklund et al.
BRAIN RESEARCH (2000)
Single or continuous injection of glial cell line-derived neurotrophic factor in the striatum induces recovery of the nigrostriatal dopaminergic system
M Aoi et al.
NEUROLOGICAL RESEARCH (2000)
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
JH Kordower et al.
SCIENCE (2000)
Convection-enhanced delivery of AAV vector in parkinsonian monkeys;: In vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach
KS Bankiewicz et al.
EXPERIMENTAL NEUROLOGY (2000)
GDNF induces recovery of the nigrostriatal dopaminergic system in the rat brain following intracerebroventricular or intraparenchymal administration
M Aoi et al.
ACTA NEUROCHIRURGICA (2000)
What contributes to quality of life in patients with Parkinson's disease?
A Schrag et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
Neurotrophic factors in Alzheimer's and Parkinson's disease brain
GJ Siegel et al.
BRAIN RESEARCH REVIEWS (2000)
分享论文
